GPRC5A and cancer: It has been suggested that highly expressed GPCRs in cancer cells (e.g., GPRC5A in PDAC and colon cancer cells and GPR68 in PDAC CAF) may contribute to malignant phenotypes and may be novel therapeutic targets for cancer as biomarkers [9].